Market Data and Evolution
The current leading therapeutic class in worldwide sales is the group of cholesterol reducing statins with overall sales of about $US15 billion in 2001. Simvastatin (Zocor®, Merck & Co.) was the top leader in sales of worldwide prescription drugs in 2001, $US 6670 millions (26.3% increase in relation to 2000). Simvastatin represents 44% of the sales in this therapeutic class.

The market in United States valued 2,854 millions USD in 2001, which represents 42,7% of simvastatin worldwide sales.

Simvastatin sales evolution from 1997 to 2001 and sales distribution by country (USA, United Kingdom, Germany, France and Japan) in 2000 and 2001, can be viewed below:

Simvastatin Sales - Graphs
This information is confidential.

If you don't have a password, please register with us, and we will give you access by return e-mail.

Please click here to view the following graphs if you have already registered with Hovione

  • Simvastatin Worldwide Sales Evolution
    (US$ millions and API tonnes)
     
  • Simvastatin Worldwide Sales by Country
    (March 2002 (US$ millions))

Marketed drug products
Zocor® is Merck Sharp & Dohme’s brand name for Simvastatin. Zocor® was first approved by the FDA in 1991.

The pharmaceutical form of Zocor® is a coated tablet, which contains as excipients cellulose, hydroxypropyl cellulose, hydroxypropyl methylcellulose, iron oxides, lactose, magnesium stearate, starch, talc, titanium dioxide and butylated hydroxyanisole as preservative1. The pharmaceutical dosages range between 5 mg and 80 mg per tablet.

Sales distribution in the United States amongst the available dosages can be viewed in the following graph as well as its evolution from 2000 and 2001. The most prescribed dosage is the 20 mg.

Simvastatin Sales - Graphs
This information is confidential.

If you don't have a password, please register with us, and we will give you access by return e-mail.

Please click here to view the following graph if you have already registered with Hovione

  • Distribution of Sales by Dosage in the US
    (Years 2000 and 2001)

Depending on the country there are different dosages available. As an example it is provided in the following table the availability of dosages in the United States, France and Germany.

Country

Brand name

Pharmaceutical dosage and Presentation

 

  

 

United States

 

 

 

Zocor®

5 mg
   bottles of 60 tablets
   bottles of 90 tablets
   bottles of 100 tablets

10 mg
  
bottles of 60 tablets
   bottles of 90 tablets
   bottles of 100 tablets

20 mg
   bottles of 60 tablets
   bottles of 100 tablets

40 mg
   bottles of 60 tablets

80 mg
   bottles of 60 tablets

 

 

 

Germany

 

 

 

Zocor®

5 mg
   blister of 30 tablets
   blister of 50 tablets
   blister of 100 tablets

10 mg
  
blister of 30 tablets
   blister of 50 tablets
   blister of 100 tablets

20 mg
   blister of 30 tablets
   blister of 50 tablets
   blister of 100 tablets

40 mg
   blister of 30 tablets
   blister of 50 tablets
   blister of 100 tablets

  

France

  

Zocor®

5 mg
   blister of 28 tablets

20 mg
   blister of 28 tablets
   blister of 50 tablets

 

1 Physicians’ Desk Reference (PDR); 55th edition; 2001.

[back to top]